Pre-exposure prophylaxis (PrEP) was conceived to fill the urgent need for a woman-controlled HIV prevention method. However, biomedical technology alone will not alter the underlying gender inequalities that make women and girls vulnerable to HIV. This technical brief was developed by Michele Lanham from FHI360 – an OPTIONS consortium partner. It focuses on addressing gender while ensuring effective PrEP introduction.
Addressing Gender to Ensure Effective PrEP Introduction
Post date: April 2017